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Abstract   
Purpose: In-room MRI is a promising image guidance strategy in external beam radiotherapy to 
acquire volumetric information for moving targets. However, limitations in spatio-temporal resolution 
led several authors to use 2D orthogonal images for guidance. The aim of this work is to present a 
method to concurrently compensate for non-rigid tumor motion and provide an approach for 3D 
reconstruction from 2D orthogonal cine-MRI slices for MRI-guided treatments. 
Methods: Free-breathing sagittal/coronal interleaved 2D cine-MRI were acquired in addition to a pre-
treatment 3D volume in two patients. We performed deformable image registration (DIR) between 
cine-MRI slices and corresponding slices in the pre-treatment 3D volume. Based on an extrapolation 
of the interleaved 2D motion fields, the 3D motion field was estimated and used to warp the pre-
treatment volume. Due to the lack of a ground truth for patients, the method was validated on a digital 
4D lung phantom. 
Results: On the phantom, the 3D reconstruction method was able to compensate for tumor motion and 
compared favorably to the results of previously adopted strategies. The difference in the 3D motion 
fields between the phantom and the extrapolated motion was 0.4±0.3mm for tumor and 0.8±1.5mm 
for whole anatomy, demonstrating feasibility of performing a 3D volumetric reconstruction directly 
from 2D orthogonal cine-MRI slices. Application of the method to patient data confirmed the 
feasibility of utilizing this method in real world scenarios. 
Conclusions: Preliminary results on phantom and patient cases confirm the feasibility of the proposed 
approach in an MRI-guided scenario, especially for non-rigid tumor motion compensation. 
  
1. Introduction 
Variability of organ shape and position in thoracic and abdominal regions due to breathing is an 
important issue in radiotherapy treatment [1] and needs to be compensated for to increase accuracy in 
target localization and dose delivery [2]. For this purpose, in-room image guidance is increasingly 
utilized for motion management [3]. Due to its exquisite soft tissue contrast, the ability to select 
arbitrary imaging planes, and the absence of imaging dose, Magnetic Resonance Imaging (MRI) is an 
ideal imaging modality to study organ motion [4,5], motivating several groups to develop integrated 
MRI-radiotherapy systems [6,7,8]. 
In current MRI scanners, real-time 3D image acquisitions during respiration is not feasible at 
clinically acceptable spatio-temporal resolution [9]. Fast dynamic MRI (i.e. cine-MRI) allows high 
temporal resolution imaging, but is limited to the acquisition of few 2D slices. The use of 2D cine-
MRI for organ motion quantification has been widely reported in the literature [10,11,12,13], and is 
current standard of care for real-time imaging in the new in-room MRI systems. However, the need to 
accurately adapt for 3D motion is of primary importance to enable accurate treatments [14]. For this 
reason, the ideal imaging strategy for in-room MRI treatment systems would yield real-time 3D 
information of both tumor and surrounding tissues. 
Several methods have been proposed in the literature to track tumor motion and derive its 3D local 
information based on 2D interleaved orthogonal cine-MRI slices [15,16,17,18]. These strategies rely 
on acquiring a pre-treatment 3D scan, extracting a target template and performing template matching 
between the template and pairs of orthogonal 2D cine-MRI intersecting the target motion path. 
However, such approaches provide only the rigid translational component of tumor motion.  
Another solution able to derive the non-rigid global 3D anatomical information is to use a patient 
specific global motion model [19,20], which could be also used for dose accumulation [29]. In this 
approach, a motion model is constructed based on 4D planning data, and updated during treatment 
based on surrogate signals (e.g. surface information or fiducial markers). Two recent works by Harris 
et al. [21] and Stemkens et al. [22] extend the use of global motion models to the MRI-guided 
scenario. Limitations of both approaches lay on (i) the use of a single surrogate to update the model 
based on a weighting factor derived from the calculation of a similarity metric between model and 2D 
cine-MRI (sagittal or coronal) and (ii) the sensitivity of the training dataset to inter- and intra-fraction 
changes. As suggested by [21], the impact of patient breathing variability between pre-treatment and 
on-board imaging needs to be studied further in the implementation of global motion models, since 
the correct estimation of tumor motion is the primary step for accurate tumor tracking treatments. 
The aim of this work is to provide an alternative strategy to solve limitations of template matching 
and global motion models in tumor motion compensation for MRI-guidance. We propose a novel 3D 
reconstruction method directly from the 2D orthogonal sagittal/coronal cine-MRI slices acquired 
during treatment by means of deformable image registration (DIR) between the cine-MRI slices and a 
pre-treatment 3D volume. Figure 1 shows a comparison of the proposed method with respect to the 
literature in a clinical MRI-guided workflow. Our method is able to directly capture the local 3D non-
rigid motion of the tumor, hence increasing tumor motion compensation accuracy. The proposed 
method additionally was also evaluated as a potential approach to provide a preliminary estimate of 
the global anatomy.  
 
2. Materials and Methods 
2.1. Dataset 
 
 
a. Phantom Dataset 
A phantom dataset was used for validation, since able to produce a consistent ground truth. Two 
different cases were generated using the XCAT lung phantom [23]. Exhale/inhale phases were 
generated and used respectively as pre-treatment 3D and ground_truth.  
The first case considered a large breathing motion (i.e. 3cm motion in the SI direction at the 
diaphragm) with a tumor centered in the middle of the right lung lobe and image spacing of 1.5mm3.  
The second case included a diaphragm motion of 16mm/4mm and a tumor motion of 8mm/4mm in 
SI/AP directions (where SI refers to superior-inferior, AP to anterior-posterior and RL to right-left). 
The tumor was located in the right lung with image spacing of 1mm3. For this latter case, an 
additional intermediate respiratory phase was obtained for comparison with a global motion model 
(see Section 2.3.b for details).    
b. Patient Dataset 
The patient dataset was composed of: 
(i) Gated 3D volumes of coronal slices, acquired at the exhale and inhale respiratory phases to 
simulate pre-treatment acquisition (i.e. pre-treatment3D) and the in-room volume (i.e. measured3D), 
respectively. A spin echo T2-weighted sequence (SPACE) was used with spacing of 1.18×1.18×5mm3.  
(ii) Free-breathing, 2D interleaved orthogonal sagittal/coronal cine-MRI images of the lung in two 
patients to simulate in-room acquisitions (i.e. cineMRI). A balanced steady-state free precession 
gradient echo T2/T1-weighted sequence (TrueFISP) was used (spacing of 1.48×1.48×5mm3; 
acquisition time: 300ms/slice) [24]. The acquisition of sagittal/coronal slices was centered in the 
tumor. The sagittal slice incorporates both the SI and the AP components, which are the main 
directions of respiratory motion. The coronal slice provides the remaining RL component, with 
redundant information regarding the SI motion.  
 
 
2.2. 3D Reconstruction Method 
The method to estimate a 3D volume from interleaved cine-MRI slices is based on the following 
steps (Figure 2): 
 
(i) 2D DIR. 2D DIR was performed between the sagittal/coronal slices of the pre-treatment3D on the 
corresponding sagittal/coronal slices from the 2D cine-MRI (sagittal and coronal cineMRI) (Figure 2, 
Panel i). 
 
(ii) 3D motion field extrapolation. The 2D sagittal and coronal motion fields components (𝑣𝑣𝑣𝑣𝑠𝑠𝑠𝑠𝑠𝑠_𝐴𝐴𝐴𝐴, 
𝑣𝑣𝑣𝑣𝑠𝑠𝑠𝑠𝑠𝑠_𝑆𝑆𝑆𝑆,  𝑣𝑣𝑣𝑣𝑐𝑐𝑐𝑐𝑐𝑐_𝑅𝑅𝑅𝑅, 𝑣𝑣𝑣𝑣𝑐𝑐𝑐𝑐𝑐𝑐_𝑆𝑆𝑆𝑆) obtained through DIR, were replicated to all the slices in the 3D space 
(e.g. the AP motion component as detected on the sagittal slice was replicated to all the other sagittal 
slices), assuming a correlation between cine-MRI motion and the whole anatomy. Redundant 
quantitative information was available in the SI direction (i.e. 𝑣𝑣𝑣𝑣𝑐𝑐𝑐𝑐𝑐𝑐_𝑆𝑆𝑆𝑆 and 𝑣𝑣𝑣𝑣𝑠𝑠𝑠𝑠𝑠𝑠_𝑆𝑆𝑆𝑆), as the orthogonal 
cine-MRI images provide a measurement of the SI component on both the sagittal and coronal plane. 
Therefore, the overall SI component of the estimated motion field was modulated by computing the 
mean of the motion field SI components (Figure 2, Panel ii). 
 
(iii) Estimated 3D image (Figure 2, Panel iii). Application of the estimated 3D motion field to the pre-
treatment3D volume in order to obtain the estimated3D volume. 
 
(iv) Analysis. Comparison between the pre-treatment3D volume and the ground_truth at the same 
respiratory phase (measured3D for patients).  
 
To assist with understanding this paper, the four different image types used in this work and their 
role are described in Table 1.   
 
2.3. 4D CT lung XCAT phantom 
a. Evaluation of the 3D reconstruction method 
The proposed approach was validated on the 4D XCAT phantom by extracting exhale/inhale 
sagittal and coronal slices to simulate the cine acquisition (c.f. cineMRI images in Figure 2). By 
setting the XCAT exhale image as a reference (pre-treatment3D), we applied the method in Section 
2.2 to generate the volume at the inhale phase (estimated3D). The XCAT inhale image was used as 
ground truth (ground_truth). 
For the phantom with 16mm/4mm motion in SI/AP, orthogonal cine-MRI slices were extracted 
with both a centered and a shifted location (5mm from the center) in the tumor. The shifted data were 
generated in order to simulate out-of-plane motion. No shifted slices were simulated on the 3cm 
motion case, due to the presence of respiratory motion only in the SI direction.  
To analyze tumor tracking accuracy, we segmented the tumor and evaluated the distance of its 
Center Of Mass (COM) and the Dice coefficient between the estimated3D volume and the 
ground_truth.  
The accuracy of the 3D reconstruction method in the surrounding anatomy was quantified by 
measuring the 3D diaphragm position [25]. For the phantom, a quantification on automatic anatomical 
landmarks [26,27] was also performed (for details see supplementary materials). An analysis on the 
motion fields was performed by comparing the estimated motion field (i.e. derived from 2D demons 
DIR, Section 2.2 point (i)) with the pre-treatment3D/ground_truth motion field obtained by means of 
a 3D b-spline DIR (www.plastimatch.org)[28].  
 
b. Comparison with other methods 
A comparison of the proposed 3D reconstruction method with template matching and global motion 
model approaches from the literature (as shown in Figure 1) was performed for the 16mm/4mm 
motion case: 
- Template matching [16]: a template was created around the tumor of the pre-treatment3D and 
searched among cineMRI. The derived rigid transformation was applied to the pre-treatment3D 
to derive estimated3D, which was then compared with the ground_truth.  
- Global motion model [20]: a model was built on the exhale volume and an intermediate 
respiratory phase (i.e. multiple pre-treatment3D volumes) by means of DIR and principal 
component analysis. The model was then updated according to the tumor motion extracted from 
cineMRI, to derive the estimated3D volume. 
The performance of each method was quantified using the same approach described in Section 2.3.a.  
 
2.4. Application to patient data 
For patients, we applied the 3D reconstruction method as shown in Figure 2 and we compared the 
estimated3D and measured3D volumes in terms of tumor motion and diaphragm position. In addition, 
the same quantification was performed on the 2D corresponding slices of cineMRI vs. estimated3D 
and cineMRI vs. measured3D, to analyze the capability of the estimated volume to include the motion 
described by the cine-MRI and to provide a quantification of the variability of the inhale phase. As for 
the phantom, an analysis on the motion fields was performed. No landmark distance was computed on 
patients since pre-treatment3D and cineMRI used to derived estimated3D were acquired with 
different MR sequences and contrast, limiting automatic landmarks identification [26,27]. 
Comparison with other methods was not implemented in patients, since multiple (4D) pre-treatment 
volumes were not available for the creation of a motion model. 
  
3. Results 
3.1. 4D CT lung XCAT phantom 
a. Performance of the 3D reconstruction method 
The 3D reconstruction method showed a good agreement between the estimated3D volume and the 
ground_truth (Figure 3, Panel A), with distances close to ground_truth. For the 16mm motion case, 
1mm distance in SI for tumor, 1.3±2.3mm for diaphragm and 1.6±3.2mm for landmarks were 
quantified (Table 2 and Figure E1 in supplementary materials). Slightly worse results were instead 
observed in the case of shifted cine-MRI slices (Figure 3, Panel B), with an error of 1-2mm in AP and 
SI for the COM.  
Figure 4 shows an example of the estimated3D close and far with respect to cine-MRI location 
(distance from the tumor of [80,80,20]mm in axial, sagittal and coronal directions respectively), with 
corresponding motion fields. The difference (mean±std(95th percentile)) between the 3D estimated 
motion field and the ground truth motion field (i.e. 3D DIR between pre-treatment3D/ground_truth) 
was 0.8±1.5(3.4) mm and 0.8±2.1(3.7) mm for the 16mm lung tumor case with centered and shifted 
slices, respectively. A difference between the two motion fields of 0.4±0.3(0.5) mm was observed at 
the tumor location for the 16mm case. The variability far from cine-MRI intersection instead was 
higher and variations were visible in organs which were not included in the field of view of the cine-
MRI slices, as visible in Figure 4 (panel B and C) near the heart. Specifically for the 3cm motion case, 
the difference in terms of motion field in the 3D reconstruction method was 1.6±3.8(4.2) mm. The 
estimated motion field was not significantly different from the ground truth motion field (Wilcoxon 
test, α=5%). 
 
b. Comparison with other methods 
Figure 5 shows the comparison of the proposed 3D reconstruction method with respect to other 
strategies. Image differences are reported between estimated3D and ground_truth. Quantitative 
analysis is shown in Table 3. For tumor region, lower errors were achieved by 3D reconstruction 
followed by template matching and global motion model. For surrounding anatomy, a good 
performance was achieved by global motion model approach and 3D reconstruction approach.  
Higher differences were notable in the motion field with respect to the ground truth motion at the 
tumor location (0.9±0.7(1.1) mm for the global motion model while 0.4±0.3(0.5) mm for the 3D 
reconstruction). However, the overall motion field difference for global motion model was 
0.4±1.7(0.9) mm (0.8±1.5(3.4) mm for 3D reconstruction), with slightly higher landmark distance for 
3D reconstruction (1.6±3.2mm for 3D reconstruction against 1.2±1.4mm for motion model). 
 
3.2. Patient data 
The estimated3D volume shows a partial overlap with the measured3D (Figure 6), with lower 
performance in P01 near the tumor and with a diaphragm distance of about 4mm for both patients 
from the measured3D (Table 4).  
However, a better overlap of cineMRI with estimated3D than with measured3D is shown in the 
tumor region and in the diaphragm for P01 and P02, respectively (Figure 7). By considering the 
coronal cineMRI and the corresponding slice in the estimated3D volume, the Dice coefficient and the 
COM distance were better in contrast to cineMRI/measured3D. This anticipate the limited accuracy of 
measured3D to be a use as ground truth for patient data, as discussed in Section 4.2. As such, in Table 
4 we highlighted in grey the accuracy of estimated3D in describing the real in-room motion provided 
by the cine-MRI data, which is not instead provided by measured3D (i.e. pre-treatment volume used 
to simulate intra-treatment). 
The difference between the estimated 3D motion field and the measured one was 3.3±3.6(5.4) mm 
and 3.8±3.1(5.8) mm (mean±std(95th percentile)) for P01 and P02, respectively. Although statistical 
analysis showed a significant difference between the two motion fields (Wilcoxon test, α=5%), the 
95th percentile was similar to the maximum voxel size (i.e. 5mm). The difference in AP, RL and SI 
was quantified as 2.1±3.1(5.3) mm, 1.8±3.2(5.2) mm and 1.2±2.6(4.8) mm for P01 and 1.6±3.5(5.0) 
mm, 2.4±4.1(5.8) mm and 1.2±3.3(4.1) mm for P02. 
 
4. Discussion 
4.1. 4D CT lung XCAT phantom 
For all the phantom cases, the proposed method provided an estimated3D volume close to  
ground_truth, showing potential of this approach to account for tumor motion and provide 3D data for 
in-room volumetric motion quantification.  
It was anticipated that the selection of orthogonal sagittal and coronal slices centered in the tumor  
would mitigate the issue of out-of-plane motion, thanks to the robust description of SI and AP motion 
(i.e. main directions of respiratory motion) [15,16,17]. Nonetheless, we also tested the algorithm in 
presence of out-of-plane motion by simulating shifted slice positioning. In this scenario, results 
showed slightly higher errors with respect to a centered selection. However, the method was able to 
compensate for motion and errors were close to the voxel size (slice thickness of 1mm in the 
phantom). Considering a centered selection of cine-MRI in the tumor for patient data, it is expected 
that out-of-plane motion will have minimal impact with respect to the phantom, since patients are 
acquired with a 5mm slice thickness. The simulation with shifted slices, allowed also to evaluate non-
rigid motion which can affect the correspondent slices between cineMRI and pre-treatment3D. With 
the advent of novel in-room MRI systems, where cine-MRI represents the state-of-the-art imaging 
modality for tumor tracking, it is expected that in-room 3D (or 4D) MRI are acquired just prior 
treatment, mitigating inter-fraction variations and providing a preliminary information of non-rigid 
motion for the definition of correspondent slices. 
The method was also tested against existing alternatives from the literature. The proposed method 
was shown to perform better than the template matching approach, which assumes that there is no 
tumor shape change between the 3D template and the 2D slice image, thus compensating only for 
rigid motion [16], as visible in Figure 5. Better results in tumor motion compensation were achieved 
by the 3D reconstruction strategy with respect to the global motion model approach [20]. Unlike the 
global motion model approach, the proposed method does not rely on training data, which results in a 
reduced sensitivity to inter and intra-fraction variability. The 3D reconstruction method instead 
directly updates the pre-treatment volume including in the estimated volume the changes occurring 
during and between treatments via 2D DIR.  
In terms of surrounding anatomy, errors in the 3D global reconstruction were higher far from the 
cine-MRI location with respect to results close to tumor location (Figure 4). This was mainly due to 
the lack of information for organs which were not included in the field of view of the cine-MRI, such 
as the heart (Figure 4). Another aspect was related to the fact that the motion field extrapolation along 
the RL and AP directions was a simple replication of the motion fields derived from 2D DIR, whereas 
the replicated SI direction was subsequently modulated by the two SI motion field components, 
featuring redundant information on both sagittal and coronal acquisitions. Our approach indeed 
assumed a correlation between the cine-MRI motion and the whole motion. This assumption is 
sufficiently valid in a neighborhood of the cine-MRI intersection (i.e. good compensation of non-rigid 
tumor motion), but limitations are still present in deriving the surrounding anatomy. As such the 
combination of our strategy with a motion model prior built on time-resolved images (i.e. 4DMRI) 
[21,22] could prove the optimal approach, providing a direct and accurate adaptation of tumor motion 
thanks to the 3D reconstruction method, with the addition of a more reliable volume estimation far 
from the cine-MRI intersection provided by the prior.  
Limitations of the XCAT phantom are linked to X-ray-based image content. Future work will be 
focused on testing the method with an MRI phantom able to simulate different MRI acquisitions. 
 
 
4.2. Patient data 
Application of the 3D reconstruction technique on patient data showed the feasibility of using this 
approach to reconstruct a 3D tumor volume from real time interleaved slices and the pre-treatment 
volume. 
Results highlighted variability between the cine-MRI and the measured3D volume 
(measured3D/cineMRI in Table 4), which limited the accuracy of measured3D as ground truth and 
made direct comparison of estimated3D with measured3D difficult. The lack of a ground truth in 
patient data is due to the impossibility of acquiring 3D data in real-time. Therefore, the validation of 
the method on the phantom highlights the applicability of the 3D reconstruction method on clinical 
MRI-guided data. 
Both patients showed a good match between estimated3D and cineMRI used to derive it 
(estimated3D/cineMRI in Table 4), both in terms of tumor and diaphragm. This suggests that our 
method is able to directly capture the intra-fraction variations occurring during respiratory motion, 
thus being able to describe the actual in-room 3D motion.  
The difference between the estimated motion field and the measured motion field (i.e. derived from 
3D DIR between pre-treatment3D and measured3D) was quantified in both patients with a mean 
value in each direction of about 2mm. The greater difference in AP and RL directions with respect to 
SI shows the limitations of the method in extrapolating a motion field in these directions.  
The difference between the pre-treatment and the cine-MRI sequence and the presence of artifacts 
in cine-MRI slices (Figure 7) affected 2D registration and subsequent 3D reconstruction. As such, the 
ability to acquire similar MR sequences for both cine-MRI and pre-treatment volumes in future 
studies would enable more robust validation on patients.  
 
5. Conclusion 
A feasibility study on the reconstruction of a 3D volume directly from 2D orthogonal cine-MRI 
slices was carried out. Results showed the capability of the method to compensate for non-rigid tumor 
motion accurately where cine-MRI are centered, by providing an alternative to existing methods for 
on-line tumor motion compensation. The method also provides a preliminary estimation of the 3D 
global anatomy, although errors are still present far from cine-MRI location. Future improvements of 
the method will aim to integrate our approach with a motion model prior, thus increasing the accuracy 
of the method in the full 3D anatomy and allowing dose calculation and adaptation. 
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Figure Legends 
Figure 1. 3D reconstruction method with respect to existing literature (i.e. template matching 
and motion model approaches). Direct extrapolation of the 3D motion from in-room 2D cine-
MRI for an MRI-guided treatment: this can be applied locally for non-rigid tumor tracking and 
additionally extended for a preliminary evaluation of the surrounding anatomy. 
Figure 2. Workflow of the proposed 3D reconstruction method. (i) DIR of the coronal/sagittal 
slices of the pre-treatment 3D volume (pre-treatment3D) on the corresponding in-room 
coronal/sagittal cine-MRI slices (cineMRI). (ii) Extrapolation of the 3D motion field from the 2D 
motion field components derived from DIR. Straight arrows for the motion field components 
derived from DIR (yellow arrow for 𝒗𝒗𝒗𝒗𝒄𝒄𝒄𝒄𝒄𝒄_𝑹𝑹𝑹𝑹, violet arrow for 𝒗𝒗𝒗𝒗𝒔𝒔𝒔𝒔𝒔𝒔_𝑨𝑨𝑨𝑨 and blue arrows for 
𝒗𝒗𝒗𝒗𝒄𝒄𝒄𝒄𝒄𝒄_𝑺𝑺𝑺𝑺 and 𝒗𝒗𝒗𝒗𝒔𝒔𝒔𝒔𝒔𝒔_𝑺𝑺𝑺𝑺), while dashed arrows represent the replication of the 2D DIR to all the 
slices with the modulation of the redundant SI component. (iii) Application of the estimated 3D 
motion field to the pre-treatment3D volume to obtain the estimated3D volume to compare (iv) 
with the ground_truth volume (measured3D for patients). 
 
Figure 3. XCAT phantom results (16mm motion case). Overlap of the estimated3D volume 
(green) obtained with the 3D reconstruction method to the ground_truth with (B) the selection of 
cine-MRI slices centered in the tumor and  (C) with a shifted selection of cine-MRI in the tumor 
to simulate out-of-plane motion. Yellow arrow indicates the tumor in the three views. 
 
Figure 4. Estimated 3D motion field. First row, (A) overlap of the estimated3D (green) with the 
ground_truth (red) close to tumor location and (B) far from the tumor location (distance from 
the tumor location of [80,80,20]mm in axial, sagittal and coronal directions respectively). 
Second row: relevant 3D estimated motion field (green arrows) along axial, sagittal and coronal 
views. Third row: 3D ground truth motion field (red arrows). Fourth row: motion field 
difference (yellow arrows) between the estimated motion field and the ground truth motion field. 
(C) Motion field difference [mm] over three portions (i.e. region of interests) along the SI 
direction; orange lines represent cine-MRI locations. 
 
Figure 5. Comparison with other methods near the tumor location (A) and far from tumor 
location (B). First raw: difference between pre-treatment3D and ground_truth to highlight the 
range of motion. Second raw: difference between the estimated volume derived via template 
matching and the ground_truth. Third raw: difference between the estimated volume derived 
via global motion model and the ground_truth. Fourth raw: difference between the estimated 
volume (estimated3D) derived via 3D reconstruction and the ground_truth. Yellow arrow 
indicates the tumor in the three views. 
 
Figure 6. Patient P01 (left column) and Patient P02 (right column). (A) Overlap of the pre-
treatment3D (green) and measured3D (red) phases to show range of motion. (B) Overlap of the 
estimated3D (green) volume obtained with the 3D reconstruction method to the measured3D 
(red) volume to show motion compensation. Image differences (grey levels) are also reported in 
the axial, sagittal and coronal views. 
 
Figure 7. Inhale variability for P01: cineMRI (green) vs. estimated3D (red) in the first row and 
cineMRI (green) vs. measured3D (red) in the second row. (A) Overlap of the coronal view. (B) 
Overlap of the sagittal view. (C) Difference in the coronal view. (D) Difference in the sagittal 
view. Yellow arrows indicate the difference around the tumor. 
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Tables 
Table 1. A summary of the acquired and estimated MRI images used in this study to perform 
and investigate the 3D reconstruction method. 
Image set Dimensionality Time of 
acquisition 
Use 
    
 pre-treatment3D 3D pre-treatment 3D image used to perform a 2D DIR with 
sagittal and coronal cineMRI slices to create 
estimated3D 
cineMRI 2D intra-treatment Interleaved 2D coronal and sagittal slices 
acquired at inhale during treatment that 
registered with the pre-treatment3D 
corresponding slices create estimated3D. 
estimated3D 3D intra-treatment 3D image created with the 3D reconstruction 
method from the 2D cineMRI and pre-
treament3D DIR. Compared with the  
ground_truth (measured3D for patients). 
ground_truth 
(measured3D for 
patients) 
3D pre-treatment (to 
simulate intra-
treatment) 
3D image compared with estimated3D 
 
 
Table 2. Distance (median ± interquartile range) between estimated3D and ground_truth for all 
the XCAT simulations in terms of Dice Coefficient, tumor COM distance [mm], diaphragm 
motion [mm] and landmark distance [mm].  
estimated3D vs. ground_truth  3cm in SI  
centered slices 
 16mm/4mm in SI/AP 
centered slices 
 16mm/4mm in SI/AP 
shifted slices 
Dice coefficient [a.u.] 0.9 0.9 0.8 
COM distance  
[RL, AP, SI] mm [0,0,1.5] [0.1,0.5,1] [0.1, 1.2, 1.5] 
Diaphragm distance [mm] 2.4±2.6 1.3±2.3 1.7±3.1 
Landmark distance [mm] 2.2±3.1 1.6±3.2 2.1±3.4 
 
 
 
Table 3. Distance (median ± interquartile range) between the ground_truth and the derived 
volume with three different strategies (case of lung tumor with 16mm/4mm in SI/AP and 
centered cine-MRI slices) in terms of Dice Coefficient and tumor COM distance [mm], 
diaphragm motion [mm] and landmark distance [mm].  
 Template matching Global motion model 3D reconstruction 
Dice coefficient [a.u.] 0.9 0.7 0.9 
COM distance  
[RL, AP, SI] mm [0.1,0.7,1.2] [0.2,1.1,1.8] [0.1,0.5,1] 
Diaphragm distance [mm] 6.2±3.8 1.9±3.5 1.3±2.3 
Landmark distance [mm] 4.0±4.2 1.2±1.4 1.6±3.2 
 
 
Table 4. Patient quantitative results. Diaphragm distance and tumor parameters (Dice 
coefficient and COM distance). Highlighted in grey the accuracy of the estimated3D volume in 
describing the real in-room motion provided by cineMRI, which is not instead provided by 
measured3D. 
 range of motion estimated3D/ 
measured3D 
estimated3D / 
cineMRI 
measured3D / cineMRI 
Patient P01 
Dice coefficient 
[a.u.] 0.7 0.6 0.9 0.6 
COM distance  
[RL, AP, SI] mm [2, 5.3, 1.5] [0.8, 3, 2.5] [0.3, 1.5, 0.8] [0.8, 4.3, 1.5] 
Diaphragm 
distance [mm] 10.6±3.5 4.7±2.4 2.5±1.9 2.9±2.0 
Patient P02 
Dice coefficient 
[a.u.] 0.9 0.9 0.9 0.8 
COM distance  
[RL, AP, SI] mm [0.3, 1.5, 0.2] [0.2, 1.5, 0.1] [0.2, 1.5, 0.1] [0.3, 1.8, 0.3] 
Diaphragm 
distance [mm] 8.3±2.3 4.7±1.6 2.4±3.2 5.9±2.6 
 
 
